Closed consultation: Proposal to Amend the Regulations for Precursors and Designated Devices
Current status: Closed
This consultation ran from January 31, 2025 to March 3, 2025.
On February 1, 2025, Health Canada published a Notice of Intent in the Canada Gazette, Part I, proposing to advance amendments to the Precursor Control Regulations and Schedule IX to the Controlled Drugs and Substances Act that would increase oversight of precursors, strengthen Canada's regulatory framework, and increase Health Canada's regulatory flexibility and agility.
New tools are needed to support law and border enforcement in their efforts to address the illegal importation of precursor chemicals and the illegal importation, production, and trafficking of fentanyl and other synthetic drugs by organized crime groups. Through Canada's Border Plan, the Government of Canada will increase support to law enforcement agencies to detect, intercept and address fentanyl and precursor chemicals. As part of this work, Health Canada will advance amendments to the regulations for precursor chemicals and drug equipment.
Who was the focus of this consultation
We engaged with:
- licensed and registered dealers of precursors
- Canadian industries using precursors
- law enforcement
- interested members of the public
Related information
Contact us
Office of Legislative and Regulatory Affairs
Controlled Substances and Overdose Response Directorate
Health Canada
Email: csd.regulatory.policy-politique.reglementaire.dsc@hc-sc.gc.ca